Needham initiates coverage of Clover Health Investments with buy rating, $6 target
CLOV•Needham initiated coverage of Clover Health Investments with a buy rating and a $6 target price.
Related News
ProPetro Q3 revenue rises 16%, beats analyst estimates
PUMP•
Raymond James raises Esquire Financial Holdings target price to $150 from $140
ESQ•
Littelfuse Q3 sales rise 23% on electronics segment strength
LFUS•
CH Robinson Q3 EPS $1.67
CHRW•
Phillips 66 posts record quarterly profit on refining strength
PSX•